Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves survival and cardiovascular outcomes in COVID-19 (2022)
Discussion in 'Epidemics (including Covid-19, not Long Covid)' started by SNT Gatchaman, Aug 15, 2022.